Author:
Hynie Sixtus,Klenerová Věra,Caicedo Martha,Šamánek Milan
Reference20 articles.
1. Brodde O-E: β1- and β2- Adrenoceptors in the human heart: Properties, function, and alterations in chronic heart failure. Pharmacol Rev 43:203–242, 1991
2. Bristow MR, Ginsburg R, Umans V, Fowler M, Minobe W, Rasmussen R, Zera P, Menlove R, Shah P, Jamieson S, Stinson EB: β1- and β2 adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective β1 -receptor down-regulation in heart failure. Circ Res 59: 297–309, 1986
3. Böhm M, Pieske B, Schnabel P, Schwinger R, Kemkes B, Klovekorn W-P, Erdmann E: Reduced effects of doxepamine on force of contractionin the failing human heart despite preserved β2-adrenoceptor subpopulation. J Cardiovascul Pharmacol 14: 549–559, 1989
4. Dickinson K E J, Nahorski S R: Identification of solubilized beta1, and beta2 adrenoceptors in mammalian lung. Life Sci 29: 2527–2533, 1981
5. Hynie S, Šamánek M, Caisedo M, Rožnová L, Hučín B, Vislocký I.: Vliv léčby beta-adrenergními blokátory na beta-adrenergní receptory v myokardu dětí s Fallotovou tetralogií. Čas Lék čes 132: 484–488, 1993